Glaxo Wellcome earmarks more for research

April 17, 1998

Pharmaceutical giant Glaxo Wellcome spent Pounds 1.15 billion on research and development in 1997, according to its annual report. The firm, which notched up global sales worth Pounds 8 billion, says it expects to spend Pounds 1.2 billion on R&D next year. It says that for the pharmaceutical industry worldwide, sales in 1997 were up 9 per cent to Pounds 166 billion.The North American market saw the greatest increase from 9 per cent growth in 1996 to 15 per cent in 1997, generating Pounds 61 billion of sales.

The United States accounts for 35 per cent of the global market. Europe has experienced a decline in growth from 9 per cent to 6 per cent. Growth in Latin America has increased from 7 per cent to 11 per cent, while in Asia Pacific growth has slowed from 13 per cent to 9 per cent.

Already registered?

Sign in now if you are already registered or a current subscriber. Or subscribe for unrestricted access to our digital editions and iPad and iPhone app.

Have your say

Log in or register to post comments

Featured Jobs

Board Member BOURNEMOUTH UNIVERSITY (MAIN OFFICE)

Most Commented

Elderly woman looking up at sky

A recent paper claims that the quality of researchers declines with age. Five senior scientists consider the data and how they’ve contributed through the years

Otto illustration (5 May 2016)

Craig Brandist on the proletarianisation of a profession and how it leads to behaviours that could hobble higher education

smiley, laugh, happy, funny, silly, face, faces

Scholars should cheer up and learn to take the rough with the smooth, says John Tregoning

Eleanor Shakespeare illustration 19 May 2016

Tim Blackman’s vision of higher education for the 21st century is one in which students of varying abilities learn successfully together

James Minchall illustration (12 May 2016)

An online experiment proves that part of the bill for complying with the Freedom of Information Act is self-inflicted, says Louis Goddard